When to Order Your Next Mounjaro Pen (and How to Get It Right)

Why timing your Mounjaro order actually matters

Each Mounjaro KwikPen contains four weekly doses, so the pen you open this week will last exactly four weeks. That sounds like plenty of notice, but the practical window is shorter than it appears. Mounjaro is a prescription-only medicine in the UK, which means every new supply requires a fresh clinical assessment, your prescriber reviews your progress, weight and any side effects before approving the next pen. That review takes time, even when things run smoothly.

A good rule of thumb is to request your next pen during the third week of your current one, which gives the consultation process room to breathe and means a same-day dispatch (for orders placed before 12pm on a weekday) can reach you well before you need it. If you are moving up to a new strength, allow extra time: higher doses are sometimes in shorter supply, and your prescriber needs to see evidence that your current dose is tolerated before signing off the increase.

There is also a storage consideration. Mounjaro must be refrigerated at 2–8°C; if your delivery is delayed and the pen has been sitting at room temperature, the exact usable window is specified in the Patient Information Leaflet, worth reading before you assume a late-arriving pen is still good to use. You can find detailed guidance on how Mounjaro works and what to expect from treatment on our main Mounjaro page.

What happens during the clinical review before each order

This is the part that surprises people who are used to clicking "reorder" on a supplement. Because Mounjaro is a prescription-only medicine, every repeat (not just the first one) requires a prescriber to actively approve it. At nume, that review is done by a named, GPhC-registered Independent Prescriber on the same day you submit your consultation, not by an automated system making a box-ticking decision.

The prescriber looks at several things: your reported weight since the last pen, any side effects you experienced, whether a dose increase is appropriate, and any new health information that might affect suitability. For dose increases in particular, evidence of tolerability at the current level is required as a matter of clinical policy. This is not bureaucracy for its own sake; it is why clinically supervised treatment produces better outcomes than a parcel arriving from an unverified seller.

If you want to understand more about what a prescriber looks for, our clinical team page sets out how oversight works at nume. For a broader look at the conditions and BMI thresholds relevant to Mounjaro eligibility, the treatment consultation page is the right starting point.

How to order your next Mounjaro pen through a registered UK pharmacy

The only legal route to Mounjaro in the UK is a valid prescription issued after clinical assessment. Online pharmacies that supply it without one are operating outside UK law, and the MHRA has warned repeatedly about fake weight-loss pens sold through social media and unregulated websites, in October 2025 enforcement teams raided a site in Northampton producing counterfeit tirzepatide pens, part of a wider crackdown on around 20 million doses of illegally traded weight-loss medicines worth roughly £45 million. Fake pens have in some cases contained insulin rather than tirzepatide; the risks are not trivial.

Before ordering from any online pharmacy, check it on the GPhC register, every registered pharmacy has a premises number you can verify in seconds. The MHRA advises treating offers of these medicines from unverified sellers, including anyone offering them without a clinical consultation, as a serious red flag. You can report suspect sellers at the MHRA Yellow Card site.

At nume, the process is straightforward: complete a free consultation online, a prescriber reviews it the same day, and if approved your pen is dispatched before 3pm for free next-working-day delivery via DPD. For answers to common questions about the ordering process, our FAQs page covers the most frequent ones.

Am I still eligible to reorder at my current dose?

Eligibility for ongoing treatment depends on the prescriber's assessment at each review, not on the fact that you received a previous pen. Mounjaro is licensed for adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, high cholesterol or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. NICE's recommendation (TA1026) sets stricter thresholds for NHS prescribing, but private prescribing follows the licensed criteria assessed individually.

If you have had fewer than five percent weight loss after six months at the highest dose you can tolerate, your prescriber may discuss whether continuing is the right call, that is a clinical conversation, not an automatic stop. The key point is that reordering is not a formality: it is a clinical decision made fresh each time, which is exactly what protects you. If you are considering switching from another provider and want to understand the transfer process, our page on where to buy Mounjaro explains what to look for. For anyone researching whether NHS access might apply to their situation, the conditions needed for NHS Mounjaro is worth reading alongside your private options.